Precision BioLogic

Specialty reagents for coagulation diagnostics

Precision BioLogic is a niche player in the coagulation diagnostics market focused on FDA cleared reagents and frozen plasmas for the North American and European markets. Customers include key reference laboratories, hospitals, treatment centers and research groups. The company directly serves over 1,000 clinical laboratories throughout North America and has a network of distributors in Europe.

Our reason to partner up

  • Low-cyclical market driven by strong trends with ageing population, new therapies, and increasing access to healthcare across the globe
  • Clear sustainability perspective of supporting access to good health, offering high-quality products
  • Research and quality driven organization with a strong management

What we add

  • Experience in building global niche market leaders
  • Financial support and willingness to make investments in organization to enable future growth
  • Identification and sourcing of suitable add-on acquisitions

Fund: PCI VII
Year of acquisition: 2024
Number of employees: c. 90
Revenue 2023: c. 13 MEUR

Related information:
Procuritas partners up with Precision BioLogic

Visit Precision BioLogic 

Visit Linkedin profile

Procuritas team

Johan Conradsson

Co-Managing Partner

Richard Kristiansson

Investment Manager

Annie Zhang

Associate

Other companies.